ivWatch is committed to improving the lives of others both in and outside of our office. We are proud of our team's dedication to giving back through the ivWatch Cares Program. The ivWatch Cares team and the National Institutes of Aerospace hosted a blood drive to...

ivWatch on WAVY TV to Discuss Business Diversity An interview with Gary Warren, president and CEO of ivWatch, and Andy Fox of WAVY TV 10, highlighted the biotech company as an example of a business driving diversity in the Hampton Roads region of Virginia....

ivWatch is committed to improving the lives of others both in and outside of our office. We are proud of our team's dedication to giving back through the ivWatch Cares Program. The ivWatch Cares team donated toiletries to support families at the local Ronald McDonald...

ivWatch’s Gary Warren Discusses Future of Healthcare and Device Development in MD+DI ivWatch President and CEO, Gary Warren, offers his insights on device development and non-traditional human factors in the Medical Device and Diagnostic Industry (MD+DI) article, “I’m...

Peripheral IVs have flown under the radar & their complications have been underreported, undocumented and often ignored. This includes complications like IV infiltration/extravasation - our top priorities.

Download Our Whitepaper

Thank you for requesting more information about the ivWatch Clinical Studies. The ivWatch Model 400 is the only continuous monitoring device for the early detection of IV infiltration and extravasation events.